Table 1.
MCF‐7 | T‐47D | KPL‐1 | KPL‐3C | |
---|---|---|---|---|
GLI1 | ↓a | NA | ↓ | ↓ |
GLI2 | NA | ↓ | ↓ | NC |
SHH | NA | ↓ | ↓ | ↓ |
NA, not applicable; NC, no change. Cells were treated with 1 nM E2 and the indicated concentrations of GANT61 for 3 days. *Significantly decreased.
MCF‐7 | T‐47D | KPL‐1 | KPL‐3C | |
---|---|---|---|---|
GLI1 | ↓a | NA | ↓ | ↓ |
GLI2 | NA | ↓ | ↓ | NC |
SHH | NA | ↓ | ↓ | ↓ |
NA, not applicable; NC, no change. Cells were treated with 1 nM E2 and the indicated concentrations of GANT61 for 3 days. *Significantly decreased.